Results
|
|
181.
|
|
|
|
182.
|
|
|
|
183.
|
|
|
|
184.
|
|
|
|
185.
|
|
|
|
186.
|
|
|
|
187.
|
|
|
|
188.
|
|
|
|
189.
|
|
|
|
190.
|
|
|
|
191.
|
Is forequarter amputation justified for palliation of intractable cancer symptoms? [electronic resource] by
- Merimsky, O
- Kollender, Y
- Inbar, M
- Lev-Chelouche, D
- Gutman, M
- Issakov, J
- Mazeh, D
- Shabat, S
- Bickels, J
- Meller, I
Producer: 20010215
In:
Oncology vol. 60
Availability: No items available.
|
|
|
192.
|
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations. [electronic resource] by
- Issakov, J
- Merimsky, O
- Gutman, M
- Kollender, Y
- Lev-Chelouche, D
- Abu-Abid, S
- Lifschitz-Mercer, B
- Inbar, M
- Klausner, J M
- Meller, I
Producer: 20000511
In:
Annals of surgical oncology vol. 7
Availability: No items available.
|
|
|
193.
|
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. [electronic resource] by
- Merimsky, O
- Meller, I
- Flusser, G
- Kollender, Y
- Issakov, J
- Weil-Ben-Arush, M
- Fenig, E
- Neuman, G
- Sapir, D
- Ariad, S
- Inbar, M
Producer: 20000223
In:
Cancer chemotherapy and pharmacology vol. 45
Availability: No items available.
|
|
|
194.
|
Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatment. [electronic resource] by
- Kovner, F
- Spigel, S
- Rider, I
- Otremsky, I
- Ron, I
- Shohat, E
- Rabey, J M
- Avram, J
- Merimsky, O
- Wigler, N
- Chaitchik, S
- Inbar, M
Producer: 19990723
In:
Journal of neuro-oncology vol. 42
Availability: No items available.
|
|
|
195.
|
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer. [electronic resource] by
- Lang, I
- Inbar, M J
- Kahán, Z
- Greil, R
- Beslija, S
- Stemmer, S M
- Kaufman, B
- Zvirbule, Z
- Steger, G G
- Messinger, D
- Brodowicz, T
- Zielinski, C
Producer: 20130304
In:
European journal of cancer (Oxford, England : 1990) vol. 48
Availability: No items available.
|
|
|
196.
|
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. [electronic resource] by
- Gotlieb, W H
- Friedman, E
- Bar-Sade, R B
- Kruglikova, A
- Hirsh-Yechezkel, G
- Modan, B
- Inbar, M
- Davidson, B
- Kopolovic, J
- Novikov, I
- Ben-Baruch, G
Producer: 19980730
In:
Journal of the National Cancer Institute vol. 90
Availability: No items available.
|
|
|
197.
|
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study. [electronic resource] by
- Ron, I G
- Wigler, N
- Borovik, R
- Brufman, G
- Rizel, S
- Shani, A
- Brenner, J
- Farbstein, H
- Dale, A
- Inbar, M J
- Brenner, H J
- Chaitchik, S
- Catane, R
Producer: 20010830
In:
American journal of clinical oncology vol. 24
Availability: No items available.
|
|
|
198.
|
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. [electronic resource] by
- Hall, M J
- Liberman, E
- Dulkart, O
- Galazan, L
- Sagiv, E
- Shmueli, E
- Kazanov, D
- Hallak, A
- Moshkowitz, M
- Figer, A
- Kraus, S
- Inbar, M
- Neugut, A I
- Arber, N
Producer: 20091109
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
|
199.
|
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients. [electronic resource] by
- Stemmer, S M
- Hardan, I
- Raz, H
- Adamou, A K
- Inbar, M
- Gottfried, M
- Merrick, Y
- Cohen, Y
- Sulkes, A
- Ben-Baruch, N
- Pfeffer, R P
- Brenner, H J
- Rizel, S
Producer: 20030714
In:
Bone marrow transplantation vol. 31
Availability: No items available.
|
|
|
200.
|
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. [electronic resource] by
- O'Brien, M E R
- Wigler, N
- Inbar, M
- Rosso, R
- Grischke, E
- Santoro, A
- Catane, R
- Kieback, D G
- Tomczak, P
- Ackland, S P
- Orlandi, F
- Mellars, L
- Alland, L
- Tendler, C
Producer: 20040712
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 15
Availability: No items available.
|